|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Asthma | |||||
| Eosinophilia | |||||
| Helminthiasis | |||||
| Hypersensitivity | |||||
| Parasitic Disease | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Parasitic Diseases | |||||
| 3 | More general conditions related to this trial | ||||
| Bronchial Diseases | |||||
| Hematologic Diseases | |||||
| Hypersensitivity, Immediate | |||||
| Immune System Diseases | |||||
| Leukocyte Disorders | |||||
| Lung Diseases | |||||
| Lung Diseases, Obstructive | |||||
| Respiratory Hypersensitivity | |||||
| Respiratory Tract Diseases | |||||
| 4 | Sponsors listed in this trial | ||||
| National Institute of Allergy and Infectious Diseases (NIAID) | |||||